Stay updated on Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial
Sign up to get notified when there's something new on the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page.

Latest updates to the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page
- Check3 days agoChange DetectedThe study record describes a Phase 2 trial of two oral insulin regimens for relatives at risk of type 1 diabetes, including its eligibility criteria, locations, and outcome measures. It also provides study dates, publications, and links to protocol and data-sharing resources.SummaryDifference52%

- Check10 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The study record remains unavailable behind a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedAn NIH-wide notice about changes in terminology from “Artificial Intelligence” to “Super Intelligence” appears above the page, replacing the prior 403 error display. The study record details are not shown.SummaryDifference2%

- Check24 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the study page’s 403 error screen.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page was updated to revision v3.7.0 and several legacy study documents and metadata entries were removed, indicating a cleanup of the study record section.SummaryDifference17%

Stay in the know with updates to Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Insulin Immune Effects in Type 1 Diabetes Risk Clinical Trial page.